0001493152-22-003030.txt : 20220202
0001493152-22-003030.hdr.sgml : 20220202
20220202190851
ACCESSION NUMBER: 0001493152-22-003030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Litchev Boyan Vesselinov
CENTRAL INDEX KEY: 0001902726
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40652
FILM NUMBER: 22585499
MAIL ADDRESS:
STREET 1: 13357 RUSSET LEAF LN.
CITY: SAN DIEGO
STATE: CA
ZIP: 92129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863158720
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 347-480-9760
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Intec Parent Inc.
DATE OF NAME CHANGE: 20210414
4
1
ownership.xml
X0306
4
2022-02-01
0
0001857044
Indaptus Therapeutics, Inc.
INDP
0001902726
Litchev Boyan Vesselinov
C/O INDAPTUS THERAPEUTICS, INC.
3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK
NY
10019
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
4.97
2022-02-01
4
A
0
90000
0
A
2032-02-01
Common Stock
90000
90000
D
The stock option vests and becomes exercisable as to one-third of the total shares on February 1, 2023 and thereafter the remaining shares vest and become exercisable in equal monthly installments over the following 24 months.
/s/ Boyan Litchev
2022-02-02